Patents by Inventor Francis Tavares

Francis Tavares has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10708393
    Abstract: Embodiments are directed to stateless communication using a stateful protocol. One or more NTMAs may establish a connection with a client computer based on data exchanged with a the client computer using the stateful protocol. The exchanged data may include validation information provided by the one or more NTMAs. The exchanged data and other information associated with the connection may be discarded from one or more memories of the one or more NTMAs. A network packet communicated over the network using the stateful protocol may be obtained. Verification information and candidate validation information may be generated based on one or more characteristics of the network packet. The network packet may be validated based on a comparison of the verification information and the candidate validation information. A reply that adheres to the stateful protocol may be provided to the client computer based on the validated network packet.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: July 7, 2020
    Assignee: F5 Networks, Inc.
    Inventors: Peter Michael Thornewell, John Francis Tavares, Robert Andrew Kovalchik
  • Publication number: 20080058333
    Abstract: Cycloalkyl ketoamide derivatives, which are useful as cathepsin K inhibitors are described herein. The described invention also includes methods of making such cycloalkyl ketoamide derivatives as well as methods of using the same in the treatment of disorders, including osteoporosis, associated with enhanced bone turnover which can ultimately lead to fracture.
    Type: Application
    Filed: August 31, 2007
    Publication date: March 6, 2008
    Inventors: John Catalano, David Deaton, Aaron Miller, Francis Tavares
  • Publication number: 20070249670
    Abstract: The invention relates to glycogen phosphorylase inhibitor compounds, pharmaceutical compositions of these compounds, methods of treatment using the pharmaceutical compositions to treat diabetes, conditions associated with diabetes, and/or tissue ischemia, including myocardial ischemia, and processes for making the compounds.
    Type: Application
    Filed: November 4, 2005
    Publication date: October 25, 2007
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Karen Evans, Maria Cichy-Knight, Frank Coppo, Kate Dwornik, Jennifer Gale, Dulce Garrido, Yue Li, Mehul Patel, Francis Tavares, Stephen Thomson, Scott Dickerson, Andrew Peat, Steven Sparks, Pierette Banker, Joel Cooper
  • Publication number: 20060194871
    Abstract: This invention relates to novel heterocycles which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), also referred to as 11 CBy, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines.
    Type: Application
    Filed: April 6, 2004
    Publication date: August 31, 2006
    Inventors: Kevin Barvian, Andrew Carpenter, Joel Cooper, Paul Feldman, Dulce Garrido, Yu Guo, Anthony Handlon, Donald Hertzog, Clifton Hyman, Andrew Peat, Gregory Peckham, Jason Speake, William Swain, Francis Tavares, Huiqiang Zhou
  • Publication number: 20060069097
    Abstract: The present invention relates generally to inhibitors of the kinases, such as GSK3, and more particularly to fused pyradazine compounds and methods of their use.
    Type: Application
    Filed: October 14, 2003
    Publication date: March 30, 2006
    Inventors: Scott Dickerson, Francis Tavares, Huiqiang Zhou
  • Publication number: 20050107616
    Abstract: Biaryl ketoamide derivatives, which are useful as cathepsin K inhibitors are described herein. The described invention also includes methods of making such biaryl ketoamide derivatives as well as methods of using the same in the treatment of disorders, including osteoporosis, associated with enhanced bone turnover which can ultimately lead to fracture.
    Type: Application
    Filed: July 23, 2002
    Publication date: May 19, 2005
    Inventors: David Gene Barrett, David Deaton, Robert Mcfadyen, Aaron Miller, John Ray, Francis Tavares, Huiqiang Zhou
  • Publication number: 20050090507
    Abstract: Fused pyradazine derivatives, which are useful as CDK inhibitors are described herein. The described invention also includes methods of making such fused pyradazines derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
    Type: Application
    Filed: December 11, 2002
    Publication date: April 28, 2005
    Inventors: Jennifer Badiang, Scott Dickerson, Philip Harris, David Jung, Michael Peel, Michael Reno, Tara Rheault, Kirk Stevens, Francis Tavares, James Veal
  • Publication number: 20050054819
    Abstract: Cycloalkyl ketoamide derivatives, which are useful as cathepsin K inhibitors are described herein. The described invention also includes methods of making such cycloalkyl ketoamide derivatives as well as methods of using the same in the treatment of disorders, including osteoporosis, associated with enhanced bone turnover which can ultimately lead to fracture.
    Type: Application
    Filed: January 15, 2003
    Publication date: March 10, 2005
    Inventors: John Catalano, David Deaton, Aaron Miller, Francis Tavares